BRIEF published on 07/29/2024 at 17:15, 2 years 1 month ago Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for GMP Manufacture of RNA MRNA Therapeutics Linea IVT Applied DNA RNA Manufacturing DsRNA Contamination
BRIEF published on 07/29/2024 at 17:15, 2 years 1 month ago Applied DNA pour présenter Linea IVT en tant que plateforme à haut rendement et atténuée par les ARNdb pour la fabrication d'ARN selon les BPF ADN Appliqué Ligne IVT Fabrication D'ARN Contamination Par L'ARNdb Thérapeutique À Base D'ARNm
BRIEF published on 07/29/2024 at 16:34, 2 years 1 month ago Knorr-Bremse AG Publishes Preliminary Q2 2024 Results and Raises Guidance Financial Results Knorr-Bremse Q2 2024 Guidance BOOST 2026
BRIEF published on 07/29/2024 at 16:34, 2 years 1 month ago Knorr-Bremse AG publie ses résultats préliminaires du deuxième trimestre 2024 et relève ses prévisions Résultats Financiers Knorr-Bremse T2 2024 Conseils BOOSTER 2026
BRIEF published on 07/29/2024 at 16:29, 2 years 1 month ago Knorr-Bremse Publishes Preliminary Q2 2024 Financial Figures and Raises 2024 Guidance Financial Figures Knorr-Bremse Q2 2024 Operating EBIT Guidance Increase
BRIEF published on 07/29/2024 at 16:29, 2 years 1 month ago Knorr-Bremse publie ses chiffres financiers préliminaires pour le deuxième trimestre 2024 et relève ses prévisions pour 2024 Chiffres Financiers Knorr-Bremse T2 2024 EBIT Opérationnel Augmentation Des Orientations
BRIEF published on 07/29/2024 at 16:20, 2 years 1 month ago Core Development Group Named a 2024 Top Commercial Solar Contractor by Solar Power World Sustainable Energy Battery Energy Storage Systems Core Development Group 2024 Top Solar Contractors Commercial Solar
BRIEF published on 07/29/2024 at 16:20, 2 years 1 month ago Core Development Group nommé meilleur entrepreneur solaire commercial en 2024 par Solar Power World L'énergie Durable Systèmes De Stockage D’énergie Par Batterie Groupe De Développement Principal Meilleurs Entrepreneurs Solaires 2024 Solaire Commercial
BRIEF published on 07/29/2024 at 16:18, 2 years 1 month ago M&G Credit Income Investment Trust Announces Equity Issue Ordinary Shares Treasury Equity Issue Investment Trust M&G Credit
BRIEF published on 07/29/2024 at 16:18, 2 years 1 month ago M&G Credit Income Investment Trust annonce une émission d'actions Trésorerie Actions Ordinaires Fiducie D'investissement Question D'équité Crédit M&G
Published on 09/12/2026 at 02:35, 10 hours 7 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 13 hours 42 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 14 hours 37 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 15 hours 17 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 19 hours 42 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 5 hours 11 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 14 hours 27 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 14 hours 31 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 16 hours 57 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 18 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 5 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 5 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 17 hours ago Availability of the 2026 Interim Financial Report
